Hua-Qiang Zhao

Hua-Qiang Zhao


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
SMShixing Ma
Shixing Ma
AZAobo Zhang
Aobo Zhang
XLXiaole Li
Xiaole Li
SZShizhou Zhang
Shizhou Zhang
SLShaopeng Liu
Shaopeng Liu
HZHua-Qiang Zhao
Hua-Qiang Zhao
Background: Due to the lack of research on the pathological mechanism of temporomandibular joint osteoarthritis (TMJOA), there are few effective treatment measures in the clinic. In recent years, microRNAs (miRs) have been demonstrated to play an important role in the pathogenesis of osteoarthritis (OA) by regulating a variety of target genes, and the latest evidence shows that miR-21-5p is specifically overexpressed in OA. The purpose of this project was to clarify whether miR-21-5p can regulate the TMJOA process by targeting Spry1. Methods: TMJOA was induced by a unilateral anterior crossbite (UAC) model, and the effect of miR-21-5p knockout on TMJOA was evaluated by toluidine blue (TB), immunohistochemical (IHC) staining, Western blotting (WB) and RT-qPCR. Primary mouse condylar chondrocytes (MCCs) were isolated, cultured and transfected with a series of mimics, inhibitors, siRNA-Spry1 or cDNA Spry1. WB, RT-qPCR, IHC and TB were used to detect the effect of miR-21-5p and its target gene Spry1 on the expression of MMP-13, VEGF and p-ERK1/2 in TMJOA. The effect of miR-21-5p on angiogenesis was evaluated by chick embryo chorioallantoic membrane (CAM) assay and WB. Results: In the UAC model, the cartilage thickness and extracellular matrix of miR-21-5p knockout mice were less damaged, and miR-21-5p and UAC model were shown to affect the expression of Spry1, IL-1β, MMP-13, and VEGF. Luciferase experiments confirmed that Spry1 was the direct target of miR-21-5p. The expression levels of Spry1, MMP-13, VEGF and p-ERK1/2 in MCCs transfected with miR-21-5p mimic were higher than those in the inhibitor group. Under the simulated inflammatory environment of IL-1β, the expression levels of MMP-13, VEGF and p-ERK1/2 were positively correlated with miR-21-5p, while Spry1 was negatively correlated with miR-21-5p. Inhibition of miR-21-5p expression and overexpression of Spry1 enhanced the inhibition of MMP-13, VEGF and p-ERK1/2 expression. MiR-21-5p had a significant role in promoting angiogenesis in the chick embryo CAM assay, and this role was clearly mediated by the ERK-MAPK signalling pathway. Conclusion: This study verified that miR-21-5p can promote the process of TMJOA by targeting Spry1, which provides a new direction for future research on the treatment of this disease.

6 November 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
HZHaoming Zhao
Haoming Zhao
SLShaopeng Liu
Shaopeng Liu
CMChuan Ma
Chuan Ma
SMShixing Ma
Shixing Ma
GCGuokun Chen
Guokun Chen
HZHua-Qiang Zhao
Hua-Qiang Zhao
The main causes of cartilage destruction during temporomandibular joint osteoarthritis (TMJOA) are extracellular matrix degradation and angiogenesis, accompanied by an increased level of matrix-degrading enzymes and proangiogenic factors. Interleukin-6 and extracellular signal-regulated kinase (ERK) signaling pathways may play a critical role in these two processes simultaneously, but researchers have not clearly determined the mechanism. We hypothesized that estrogen-related receptor γ (ERRγ) is involved in both cartilage degeneration and angiogenesis in TMJOA. The interactions between ERRγ and the Mmp9 and Vegfa promoter regions were investigated using a chromatin immunoprecipitation (ChIP) assay. A chick embryo chorioallantoic membrane (CAM) assay was performed to investigate the inhibitory effects of U0126 and GSK5182 on angiogenesis. Western blotting, RT-qPCR, immunofluorescence staining, toluidine blue staining and transfection with cDNAs or siRNAs were performed on primary mandibular condylar chondrocytes (MCCs). Unilateral anterior crossbite (UAC)-induced TMJOA models were established in rats, and Western blotting, RT-qPCR, immunohistochemistry and Safranin O-Fast Green staining were performed to evaluate changes in vivo. ERK1/2 activated matrix metalloproteinase-9 (MMP9) and vascular endothelial growth factor-A (VEGFA), which are involved in cartilage destruction, through ERRγ. Based on the ChIP assay results, ERRγ directly activated the transcription of the Mmp9 and Vegfa genes. In chick embryo CAM models, U0126 and GSK5182 significantly inhibited angiogenesis. In conclusion, ERRγ is a downstream transcription factor of ERK1/2, and its upregulation leads to extracellular matrix degradation and angiogenesis in TMJOA. This study identified a common factor between inflammation and vascularization in OA as well as a new therapeutic target for OA: ERRγ.

1 January 2019
Verified
Journal Article
Closed access
YCYun Chen
Yun Chen
BZBingjie Zhao
Bingjie Zhao
YZYong Zhu
Yong Zhu
HZHua-Qiang Zhao
Hua-Qiang Zhao
CMChuan Ma
Chuan Ma

18 September 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
GCGuokun Chen
Guokun Chen
HZHaoming Zhao
Haoming Zhao
SMShixing Ma
Shixing Ma
LCLei Chen
Lei Chen
GWGaoyi Wu
Gaoyi Wu
HZHua-Qiang Zhao
Hua-Qiang Zhao
The purpose of this study was to elucidate the role of the circadian gene Bmal1 in human cartilage and its crosstalk with the MAPK/ERK signaling pathway in temporomandibular joint osteoarthritis (TMJ-OA). We verified the periodical variation of the circadian gene Bmal1 and then established a modified multiple platform method (MMPM) to induce circadian rhythm disturbance leading to TMJ-OA. IL-6, p-ERK, and Bmal1 mRNA and protein expression levels were assessed by real-time RT-PCR and immunohistochemistry. Chondrocytes were treated with an ERK inhibitor (U0126), siRNA and plasmid targeting Bmal1 under IL-6 simulation; then, the cells were subjected to Western blotting to analyze the relationship between Bmal1 and the MAPK/ERK pathway. We found that sleep rhythm disturbance can downregulate the circadian gene BMAL-1 and improve phosphorylated ERK (p-ERK) and IL-6 levels. Furthermore, Bmal1 siRNA transfection was sufficient to improve the p-ERK level and aggravate OA-like gene expression changes under IL-6 stimulation. Bmal1 overexpression relieved the alterations induced by IL-6, which was consistent with the effect of U0126 (an ERK inhibitor). However, we also found that BMAL1 upregulation can decrease ERK phosphorylation, whereas ERK downregulation did not change BMAL1 expression. Collectively, this study provides new insight into the regulatory mechanism that links chondrocyte BMAL1 to cartilage maintenance and repair in TMJ-OA via the MAPK/ERK pathway and suggests that circadian rhythm disruption is a risk factor for TMJ-OA.

1 April 2019 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
HZHaoming Zhao
Haoming Zhao
SLShaopeng Liu
Shaopeng Liu
ZWZuping Wu
Zuping Wu
HZHua-Qiang Zhao
Hua-Qiang Zhao
CMChuan Ma
Chuan Ma

1 January 2019 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
AZAobo Zhang
Aobo Zhang
HTHuasong Tang
Huasong Tang
SLShaopeng Liu
Shaopeng Liu
CMChuan Ma
Chuan Ma
SMShixing Ma
Shixing Ma
HZHua-Qiang Zhao
Hua-Qiang Zhao